Bioengineered nanoparticles for siRNA delivery

Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology

Volumn 5, Issue 5, 2013, Pages 449-468

  Kozielski, Kristen L ^a,b   Tzeng, Stephany Y ^a,b   Green, Jordan J ^a,b,c  

^a Johns Hopkins University   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA DELIVERY; LABORATORY TOOLS; NANOPARTICLE (NPS); NON-PROTEIN-CODING GENE; NUCLEIC ACID DELIVERIES; RNA INTERFERENCE; SHORT INTERFERING RNA (SIRNA); SIRNA DELIVERY;

BIOLOGICAL MATERIALS; DRUG THERAPY; NANOPARTICLES;

RNA;

BIOMATERIAL; CALCIUM PHOSPHATE; GOLD; INORGANIC COMPOUND; LIPID; NANOPARTICLE; NUCLEIC ACID; POLYMER; QUANTUM DOT; SILICON DIOXIDE; SMALL INTERFERING RNA;

ARTICLE; BIOCOMPATIBILITY; BIOENGINEERING; DEGRADATION KINETICS; ENDOSOME; GENE DELIVERY SYSTEM; GENE TARGETING; HUMAN; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; MOLECULAR STABILITY; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIOENGINEERING; CALCIUM PHOSPHATES; DRUG ADMINISTRATION ROUTES; DRUG DELIVERY SYSTEMS; ENDOSOMES; GOLD; HUMANS; LIPIDS; LIPOSOMES; NANOMEDICINE; NANOPARTICLES; POLYMERS; QUANTUM DOTS; RNA; RNA INTERFERENCE; RNA, SMALL INTERFERING; SILICON DIOXIDE;

EID: 84884816390     PISSN: 19395116     EISSN: 19390041     Source Type: Journal    
DOI: 10.1002/wnan.1233     Document Type: Article

References (156)

1. Fire A, Xu SQ, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998, 391:806-811.
2. Baulcombe D. RNA silencing in plants. Nature 2004, 431:356-363.
3. Sanchez-Vargas I, Travanty EA, Keene KM, Franz AWE, Beaty BJ, Blair CD, Olson KE. RNA interference, arthropod-borne viruses, and mosquitoes. Virus Res 2004, 102:65-74.
4. Voinnet O. Induction and suppression of RNA silencing: insights from viral infections. Nat Rev Genet 2005, 6:206-220.
5. Kuwabara PE, Coulson A. RNAi-prospects for a general technique for determining gene function. Parasitol Today 2000, 16:347-349.
6. Wu W, Sun M, Zou GM, Chen J. MicroRNA and cancer: current status and prospective. Int J Cancer 2007, 120:953-960.
7. Yadav S, van Vlerken LE, Little SR, Amiji MM. Evaluations of combination MDR-1 gene silencing and paclitaxel administration in biodegradable polymeric nanoparticle formulations to overcome multidrug resistance in cancer cells. Cancer Chemother Pharmacol 2009, 63:711-722.
8. Hannon GJ. RNA interference. Nature 2002, 418:244-251.
9. Boxem M, Srinivasan DG, van den Heuvel S. The Caenorhabditis elegans gene ncc-1 encodes a cdc2-related kinase required for M phase in meiotic and mitotic cell divisions, but not for S phase. Development 1999, 126:2227-2239.
10. Longman D, Johnstone IL, Caceres JF. Functional characterization of SR and SR-related genes in Caenorhabditis elegans. EMBO J 2000, 19:1625-1637.
11. Svoboda P, Stain P, Hayashi H, Schultz RM. Selective reduction of dormant maternal mRNAs in mouse oocytes by RNA interference. Development 2000, 127:4147-4156.
12. Clemens JC, Worby CA, Simonson-Leff N, Muda M, Maehama T, Hemmings BA, Dixon JE. Use of double-stranded RNA interference in Drosophila cell lines to dissect signal transduction pathways. Proc Natl Acad Sci 2000, 97:6499-6503.
13. Stark GR, Kerr IM, Williams BRG, Silverman RH, Schreiber RD. How cells respond to interferons. Annu Rev Biochem 1998, 67:227-264.
14. Thomas CE, Ehrhardt A, Kay MA. Progress and problems with the use of viral vectors for gene therapy. Nat Rev Genet 2003, 4:346-358.
15. Pack DW, Hoffman AS, Pun S, Stayton PS. Design and development of polymers for gene delivery. Nat Rev Drug Discov 2005, 4:581-593.
16. Li HJ, Chang C, Weiskopf M. Helix-coil transition in nucleoprotein-chromatin structure. Biochemistry 1973, 12:1763-1772.
17. Wu GY, Wu CH. Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. J Biol Chem 1987, 262:4429-4432.
18. Wagner E, Plank C, Zatloukal K, Cotten M, Birnstiel ML. Influenza-virus hemagglutinin-Ha-2N-terminal fusogenic peptides augment gene-transfer by transferrin polylysine DNA complexes-toward a synthetic virus-like gene-transfer vehicle. Proc Natl Acad Sci 1992, 89:7934-7938.
19. Curiel DT, Agarwal S, Wagner E, Cotten M. Adenovirus enhancement of transferrin polylysine-mediated gene delivery. Proc Natl Acad Sci 1991, 88:8850-8854.
20. Midoux P, Monsigny M. Efficient gene transfer by histidylated polylysine pDNA complexes. Bioconjugate Chem 1999, 10:406-411.
21. Vadiei K, Lopez-Berestein G, Perez-Soler R, Luke DR. In vitro evaluation of liposomal cyclosporine. Int J Pharm 1989, 57:133-138.
22. Scherphof GL, Dijkstra J, Spanjer HH, Derksen JT, Roerdink FH. Uptake and intracellular processing of targeted and nontargeted liposomes by rat Kupffer cells in vivo and in vitro. Ann N Y Acad Sci 1985, 446:368-384.
23. Alving CR, Steck EA, Chapman WL Jr, Waits VB, Hendricks LD, Swartz GM Jr, Hanson WL. Therapy of leishmaniasis: superior efficacies of liposome-encapsulated drugs. Proc Natl Acad Sci 1978, 75:2959-2963.
24. Wightman L, Kircheis R, Rossler V, Carotta S, Ruzicka R, Kursa M, Wagner E. Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo. J Gene Med 2001, 3:362-372.
25. Ogris M, Steinlein P, Kursa M, Mechtler K, Kircheis R, Wagner E. The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells. Gene Ther 1998, 5:1425-1433.
26. Ward CM, Read ML, Seymour LW. Systemic circulation of poly(L-lysine)/DNA vectors is influenced by polycation molecular weight and type of DNA: differential circulation in mice and rats and the implications for human gene therapy. Blood 2001, 97:2221-2229.
27. Ogris M, Brunner S, Schuller S, Kircheis R, Wagner E. PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther 1999, 6:595-605.
28. Mao HQ, Roy K, Troung-Le VL, Janes KA, Lin KY, Wang Y, August JT, Leong KW. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Release 2001, 70:399-421.
29. Kaul G, Amiji M. Tumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: In vitro and in vivo studies. Pharmaceut Res 2005, 22:951-961.
30. Suk JS, Suh J, Choy K, Lai SK, Fu J, Hanes J. Gene delivery to differentiated neurotypic cells with RGD and HIV Tat peptide functionalized polymeric nanoparticles. Biomaterials 2006, 27:5143-5150.
31. Hatakeyama H, Akita H, Kogure K, Oishi M, Nagasaki Y, Kihira Y, Ueno M, Kobayashi H, Kikuchi H, Harashima H. Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid. Gene Ther 2007, 14:68-77.
32. Kawano T, Yamagata M, Takahashi H, Niidome Y, Yamada S, Katayama Y, Niidome T. Stabilizing of plasmid DNA in vivo by PEG-modified cationic gold nanoparticles and the gene expression assisted with electrical pulses. J Control Release 2006, 111:382-389.
33. Meyer M, Wagner E. pH-responsive shielding of non-viral gene vectors. Expert Opin Drug Deliv 2006, 3:563-571.
34. Hafez I, Maurer N, Cullis P. On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids. Gene Ther 2001, 8:1188-1196.
35. Xu Y, Szoka FC Jr. Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry 1996, 35:5616-5623.
36. Zelphati O, Szoka FC Jr. Mechanism of oligonucleotide release from cationic liposomes. Proc Natl Acad Sci 1996, 93:11493-11498.
37. Verma A, Stellacci F. Effect of surface properties on nanoparticle-cell interactions. Small 2010, 6:12-21.
38. Lockman PR, Koziara JM, Mumper RJ, Allen DD. Nanoparticle surface charges alter blood-brain barrier integrity and permeability. J Drug Target 2004, 12:635-641.
39. Subbarao NK, Parente RA, Szoka FC Jr, Nadasdi L, Pongracz K. The pH-dependent bilayer destabilization by an amphipathic peptide. Biochemistry 1987, 26:2964-2972.
40. Wyman TB, Nicol F, Zelphati O, Scaria P, Plank C, Szoka FC Jr. Design, synthesis, and characterization of a cationic peptide that binds to nucleic acids and permeabilizes bilayers. Biochemistry 1997, 36:3008-3017.
41. Niidome T, Ohmori N, Ichinose A, Wada A, Mihara H, Hirayama T, Aoyagi H. Binding of cationic α-helical peptides to plasmid DNA and their gene transfer abilities into cells. J Biol Chem 1997, 272:15307-15312.
42. Plank C, Oberhauser B, Mechtler K, Koch C, Wagner E. The influence of endosome-disruptive peptides on gene-transfer using synthetic virus-like gene-transfer systems. J Biol Chem 1994, 269:12918-12924.
43. Frankel AD, Pabo CO. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 1988, 55:1189-1193.
44. Green M, Loewenstein PM. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 1988, 55:1179-1188.
45. Manickam DS, Bisht HS, Wan L, Mao GZ, Oupicky D. Influence of TAT-peptide polymerization on properties and transfection activity of TAT/DNA polyplexes. J Control Release 2005, 102:293-306.
46. Shmueli RB, Anderson DG, Green JJ. Electrostatic surface modifications to improve gene delivery. Expert Opin Drug Del 2010, 7:535-550.
47. Harris TJ, Green JJ, Fung PW, Langer R, Anderson DG, Bhatia SN. Tissue-specific gene delivery via nanoparticle coating. Biomaterials 2010, 31:998-1006.
48. Cheng CJ, Saltzman WM. Enhanced siRNA delivery into cells by exploiting the synergy between targeting ligands and cell-penetrating peptides. Biomaterials 2011, 32:6194-6203.
49. Zhou J, Neff CP, Swiderski P, Li H, Smith DD, Aboellail T, Remling-Mulder L, Akkina R, Rossi JJ. Functional in vivo delivery of multiplexed anti-HIV-1 siRNAs via a chemically synthesized aptamer with a sticky bridge. Mol Ther 2013, 21:192-200.
50. Boussif O, Lezoualch F, Zanta MA, Mergny MD, Scherman D, Demeneix B, Behr JP. A versatile vector for gene and oligonucleotide transfer into cells in culture and in-vivo-polyethylenimine. Proc Natl Acad Sci 1995, 92:7297-7301.
51. Benjaminsen RV, Mattebjerg MA, Henriksen JR, Moghimi SM, Andresen TL. The possible 'proton sponge' effect of polyethylenimine (PEI) does not include change in lysosomal pH. Mol Ther 2013, 21:149-157.
52. Sonawane ND, Szoka FC, Verkman AS. Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J Biol Chem 2003, 278:44826-44831.
53. Nel AE, Madler L, Velegol D, Xia T, Hoek EMV, Somasundaran P, Klaessig F, Castranova V, Thompson M. Understanding biophysicochemical interactions at the nano-biointerface. Nature Mater 2009, 8:543-557.
54. Okuda T, Sugiyama A, Niidome T, Aoyagi H. Characters of dendritic poly(L-lysine) analogues with the terminal lysines replaced with arginines and histidines as gene carriers in vitro. Biomaterials 2004, 25:537-544.
55. Benns JM, Choi JS, Mahato RI, Park JS, Kim SW. pH-sensitive cationic polymer gene delivery vehicle: N-Ac-poly(L-histidine)-graft-poly(L-lysine) comb shaped polymer. Bioconjugate Chem 2000, 11:637-645.
56. Haensler J, Szoka FC Jr. Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjugate Chem 1993, 4:372-379.
57. Vader P, van der Aa LJ, Engbersen JFJ, Storm G, Schiffelers RM. Disulfide-based poly(amido amine)s for siRNA delivery: effects of structure on sirna complexation, cellular uptake, gene silencing and toxicity. Pharmaceut Res 2011, 28:1013-1022.
58. Felgner JH, Kumar R, Sridhar CN, Wheeler CJ, Tsai YJ, Border R, Ramsey P, Martin M, Felgner PL. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J Biol Chem 1994, 269:2550-2561.
59. El Ouahabi A, Thiry M, Pector V, Fuks R, Ruysschaert JM, Vandenbranden M. The role of endosome destabilizing activity in the gene transfer process mediated by cationic lipids. FEBS Lett 1997, 414:187-192.
60. Drummond DC, Zignani M, Leroux JC. Current status of pH-sensitive liposomes in drug delivery. Prog Lipid Res 2000, 39:409-460.
61. Gary DJ, Puri N, Won YY. Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery. J Control Release 2007, 121:64-73.
62. Luo D, Saltzman WM. Synthetic DNA delivery systems. Nat Biotechnol 2000, 18:33-37.
63. Kawasaki H, Taira K. Short hairpin type of dsRNAs that are controlled by tRNAVal promoter significantly induce RNAi-mediated gene silencing in the cytoplasm of human cells. Nucleic Acids Res 2003, 31:700-707.
64. Lynn DM, Langer R. Degradable poly (β-amino esters): synthesis, characterization, and self-assembly with plasmid DNA. J Am Chem Soc 2000, 122:10761-10768.
65. Tzeng SY, Green JJ. Subtle changes to polymer structure and degradation mechanism enable highly effective nanoparticles for siRNA and DNA delivery to human brain cancer. Adv Healthcare Mater 2013, 2:468-480.
66. Son S, Namgung R, Kim J, Singha K, Kim WJ. Bioreducible polymers for gene silencing and delivery. Acc Chem Res 2012, 45:1100-1112.
67. Elbakry A, Zaky A, Liebl R, Rachel R, Goepferich A, Breunig M. Layer-by-layer assembled gold nanoparticles for siRNA delivery. Nano Lett 2009, 9:2059-2064.
68. Lee JS, Green JJ, Love KT, Sunshine J, Langer R, Anderson DG. Gold, poly (β-amino ester) nanoparticles for small interfering RNA delivery. Nano Lett 2009, 9:2402-2406.
69. Spagnou S, Miller AD, Keller M. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA. Biochemistry 2004, 43:13348-13356.
70. Hill IR, Garnett MC, Bignotti F, Davis SS. In vitro cytotoxicity of poly(amidoamine)s: relevance to DNA delivery. Biochim Biophys Acta 1999, 1427:161-174.
71. Lim YB, Han SO, Kong HU, Lee Y, Park JS, Jeong B, Kim SW. Biodegradable polyester, poly[α-(4 aminobutyl)-L-glycolic acid], as a non-toxic gene carrier. Pharmaceut Res 2000, 17:811-816.
72. Forrest ML, Koerber JT, Pack DW. A degradable polyethylenimine derivative with low toxicity for highly efficient gene delivery. Bioconjugate Chem 2003, 14:934-940.
73. Sutton D, Kim SJ, Shuai XT, Leskov K, Marques JT, Williams BRG, Boothman DA, Gao JM. Efficient suppression of secretory clusterin levels by polymer-siRNA nanocomplexes enhances ionizing radiation lethality in human MCF-7 breast cancer cells in vitro. Int J Nanomed 2006, 1:155-162.
74. Grayson ACR, Doody AM, Putnam D. Biophysical and structural characterization of polyethylenimine-mediated siRNA delivery in vitro. Pharmaceut Res 2006, 23:1868-1876.
75. Hagerman PJ. Flexibility of RNA. Annu Rev Biophys Biomol Struct 1997, 26:139-156.
76. Kebbekus P, Draper DE, Hagerman P. Persistence length of RNA. Biochemistry 1995, 34:4354-4357.
77. Bolcato-Bellemin AL, Bonnet ME, Creusatt G, Erbacher P, Behr JP. Sticky overhangsenhance siRNA-mediated gene silencing. Proc Natl Acad Sci 2007, 104:16050-16055.
78. Li SD, Chen YC, Hackett MJ, Huang L. Tumor-targeted delivery of siRNA by self-assembled nanoparticles. Mol Ther 2008, 16:163-169.
79. Adair JH, Parette MP, Altinoglu EI, Kester M. Nanoparticulate alternatives for drug delivery. ACS Nano 2010, 4:4967-4970.
80. Chono S, Li SD, Conwell CC, Huang L. An efficient and low immunostimulatory nanoparticle formulation for systemic siRNA delivery to the tumor. J Control Release 2008, 131:64-69.
81. Akinc A, Goldberg M, Qin J, Dorkin JR, Gamba-Vitalo C, Maier M, Jayaprakash KN, Jayaraman M, Rajeev KG, Manoharan M, et al. Development of lipidoid-siRNA formulations for systemic delivery to the liver. Mol Ther 2009, 17:872-879.
82. Akinc A, Zumbuehl A, Goldberg M, Leshchiner ES, Busini V, Hossain N, Bacallado SA, Nguyen DN, Fuller J, Alvarez R, et al. A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nat Biotechnol 2008, 26:561-569.
83. Lu JJ, Langer R, Chen JZ. A novel mechanism is involved in cationic lipid-mediated functional siRNA delivery. Mol Pharm 2009, 6:763-771.
84. Umeda M, Nojima S, Inoue K. Effect of lipid composition on HVJ-mediated fusion of glycophorin liposomes to erythrocytes. J Biochem 1985, 97:1301-1310.
85. Heyes J, Palmer L, Bremner K, MacLachlan I. Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids. J Control Release 2005, 107:276-287.
86. Semple SC, Akinc A, Chen J, Sandhu AP, Mui BL, Cho CK, Sah DW, Stebbing D, Crosley EJ, Yaworski E, et al. Rational design of cationic lipids for siRNA delivery. Nat Biotechnol 2010, 28:172-176.
87. Meyer M, Philipp A, Oskuee R, Schmidt C, Wagner E. Breathing life into polycations: functionalization with pH-responsive endosomolytic peptides and polyethylene glycol enables siRNA delivery. J Am Chem Soc 2008, 130:3272.
88. Zhou J, Patel TR, Fu M, Bertram JP, Saltzman WM. Octa-functional PLGA nanoparticles for targeted and efficient siRNA delivery to tumors. Biomaterials 2012, 33:583-591.
89. Mok H, Park TG. Self-crosslinked and reducible fusogenic peptides for intracellular delivery of siRNA. Biopolymers 2008, 89:881-888.
90. Yuan XD, Shah BA, Kotadia NK, Li JA, Gu H, Wu ZQ. The development and mechanism studies of cationic chitosan-modified biodegradable PLGA nanoparticles for efficient siRNA drug delivery. Pharmaceut Res 2010, 27:1285-1295.
91. Matsumoto S, Christie RJ, Nishiyama N, Miyata K, Ishii A, Oba M, Koyama H, Yamasaki Y, Kataoka K. Environment-responsive block copolymer micelles with a disulfide cross-linked core for enhanced siRNA delivery. Biomacromolecules 2009, 10:119-127.
92. van der Aa L, Vader P, Storm G, Schiffelers R, Engbersen J. Optimization of poly (amido amine) s as vectors for siRNA delivery. J Control Release 2011, 150:177-186.
93. Christie RJ, Matsumoto Y, Miyata K, Nomoto T, Fukushima S, Osada K, Halnaut J, Pittella F, Kim HJ, Nishiyama N, et al. Targeted polymeric micelles for siRNA treatment of experimental cancer by intravenous injection. ACS Nano 2012, 6:5174-5189.
94. Tzeng SY, Yang PH, Grayson WL, Green JJ. Synthetic poly(ester amine) and poly(amido amine) nanoparticles for efficient DNA and siRNA delivery to human endothelial cells. Int J Nanomed 2012, 6:3309-3322.
95. Vandenbroucke RE, De Geest BG, Bonne S, Vinken M, Van Haecke T, Heimberg H, Wagner E, Rogiers V, De Smedt SC, Demeester J, et al. Prolonged gene silencing in hepatoma cells and primary hepatocytes after small interfering RNA delivery with biodegradable poly(β-amino esters). J Gene Med 2008, 10:783-794.
96. Tzeng SY, Hung BP, Grayson WL, Green JJ. Cystamine-terminated poly(β-amino ester)s for siRNA delivery to human mesenchymal stem cells and enhancement of osteogenic differentiation. Biomaterials 2012, 33:8142-8151.
97. Breunig M, Hozsa C, Lungwitz U, Watanabe K, Umeda I, Kato H, Goepferich A. Mechanistic investigation of poly (ethylene imine)-based siRNA delivery: disulfide bonds boost intracellular release of the cargo. J Control Release 2008, 130:57-63.
98. Jeong JH, Christensen LV, Yockman JW, Zhong ZY, Engbersen JFJ, Kim WJ, Feijen J, Kim SW. Reducible poly(amido ethylenimine) directed to enhance RNA interference. Biomaterials 2007, 28:1912-1917.
99. Christensen LV, Chang CW, Kim WJ, Kim SW, Zhong ZY, Lin C, Engbersen JFJ, Feijen J. Reducible poly(amido ethylenimine)s designed for triggered intracellular gene delivery. Bioconjugate Chem 2006, 17:1233-1240.
100. Vader P, van der Aa LJ, Engbersen JFJ, Storm G, Schiffelers RM. Physicochemical and biological evaluation of siRNA polyplexes based on PEGylated poly (amido amine) s. Pharmaceut Res 2012, 29:352-361.
101. Tanaka T, Mangala LS, Vivas-Mejia PE, Nieves-Alicea R, Mann AP, Mora E, Han HD, Shahzad MM, Liu X, Bhavane R, et al. Sustained small interfering RNA delivery by mesoporous silicon particles. Cancer Res 2010, 70:3687-3696.
102. Giljohann DA, Seferos DS, Prigodich AE, Patel PC, Mirkin CA. Gene regulation with polyvalent siRNA-nanoparticle conjugates. J Am Chem Soc 2009, 131:2072-2073.
103. Zheng D, Giljohann DA, Chen DL, Massich MD, Wang XQ, Iordanov H, Mirkin CA, Paller AS. Topical delivery of siRNA-based spherical nucleic acid nanoparticle conjugates for gene regulation. Proc Natl Acad Sci 2012, 109:11975-11980.
104. Derfus AM, Chen AA, Min DH, Ruoslahti E, Bhatia SN. Targeted quantum dot conjugates for siRNA delivery. Bioconjugate Chem 2007, 18:1391-1396.
105. Kim SH, Jeong JH, Lee SH, Kim SW, Park TG. Local and systemic delivery of VEGF siRNA using polyelectrolyte complex micelles for effective treatment of cancer. J Control Release 2008, 129:107-116.
106. Singh N, Agrawal A, Leung AKL, Sharp PA, Bhatia SN. Effect of nanoparticle conjugation on gene silencing by RNA interference. J Am Chem Soc 2010, 132:8241-8243.
107. Kim SH, Jeong JH, Lee SH, Kim SW, Park TG. PEG conjugated VEGF siRNA for anti-angiogenic gene therapy. J Control Release 2006, 116:123-129.
108. Lee JB, Hong J, Bonner DK, Poon Z, Hammond PT. Self-assembled RNA interference microsponges for efficient siRNA delivery. Nature Mater 2012, 11:316-322.
109. Mok H, Lee SH, Park JW, Park TG. Multimeric small interfering ribonucleic acid for highly efficient sequence-specific gene silencing. Nature Mater 2010, 9:272-278.
110. Cutler JI, Zhang K, Zheng D, Auyeung E, Prigodich AE, Mirkin CA. Polyvalent nucleic acid nanostructures. J Am Chem Soc 2011, 133:9254-9257.
111. Forbes DC, Peppas NA. Oral delivery of small RNA and DNA. J Control Release 2012, 162:435-438.
112. Dalby B, Cates S, Harris A, Ohki EC, Tilkins ML, Price PJ, Ciccarone VC. Advanced transfection with Lipofectamine 2000 reagent: primary neurons, siRNA, and high-throughput applications. Methods 2004, 33:95-103.
113. Ma Z, Li J, He FT, Wilson A, Pitt B, Li S. Cationic lipids enhance siRNA-mediated interferon response in mice. Biochem Biophys Res Commun 2005, 330:755-759.
114. Palliser D, Chowdhury D, Wang QY, Lee SJ, Bronson RT, Knipe DM, Lieberman J. An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection. Nature 2006, 439:89-94.
115. Judge AD, Bola G, Lee ACH, Maclachlan I. Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo. Mol Ther 2006, 13:494-505.
116. Litzinger DC, Huang L. Phosphatidylethanolamine liposomes-drug delivery, gene-transfer and immunodiagnostic applications. Biochim Biophys Acta 1992, 1113:201-227.
117. Hafez IM, Cullis PR. Roles of lipid polymorphism in intracellular delivery. Adv Drug Deliv Rev 2001, 47:139-148.
118. Love KT, Mahon KP, Levins CG, Whitehead KA, Querbes W, Dorkin JR, Qin J, Cantley W, Qin LL, Racie T, et al. Lipid-like materials for low-dose, in vivo gene silencing. Proc Natl Acad Sci 2010, 107:1864-1869.
119. Leconet W, Petit P, Peraldi-Roux S, Bresson D. Nonviral delivery of small interfering RNA into pancreas-associated immune cells prevents autoimmune diabetes. Mol Ther 2012, 20:2315-2325.
120. TKM 080301 for Primary or Secondary Liver Cancer. Available at: http://clinicaltrials.gov/ct2/show/NCT01437007. (Accessed 2013).
121. Dose Escalation Study to Determine Safety, Pharmacokinetics, and Pharmacodynamics of Intravenous TKM-080301. Available at: http://clinicaltrials.gov/show/NCT01262235. (Accessed 2013)
122. Trial to Evaluate Safety and Tolerability of ALN-TTR01 in Transthyretin (TTR) Amyloidosis. Available at: http://clinicaltrials.gov/show/NCT01148953. (Accessed 2013)
123. Study With Atu027 in Patients With Advanced Solid Cancer. Available at: http://clinicaltrials.gov/ct2/show/study/NCT00938574. (Accessed 2013)
124. Kakizawa Y, Harada A, Kataoka K. Environment-sensitive stabilization of core-shell structured polyion complex micelle by reversible cross-linking of the core through disulfide bond. J Am Chem Soc 1999, 121:11247-11248.
125. Kakizawa Y, Harada A, Kataoka K. Glutathione-sensitive stabilization of block copolymer micelles composed of antisense DNA and thiolated poly (ethylene glycol)-b lock-poly (l-lysine): a potential carrier for systemic delivery of antisense DNA. Biomacromolecules 2001, 2:491-497.
126. Miyata K, Kakizawa Y, Nishiyama N, Harada A, Yamasaki Y, Koyama H, Kataoka K. Block catiomer polyplexes with regulated densities of charge and disulfide cross-linking directed to enhance gene expression. J Am Chem Soc 2004, 126:2355-2361.
127. Bernstein E, Caudy AA, Hammond SM, Hannon GJ. Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 2001, 409:363-366.
128. Kozielski KL, Tzeng SY, Green JJ. A bioreducible linear poly(β-amino ester) for siRNA delivery. Chem Commun 2013, 49:5319-5321.
129. Woodrow KA, Cu Y, Booth CJ, Saucier-Sawyer JK, Wood MJ, Saltzman WM. Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA. Nature Mater 2009, 8:526-533.
130. Tzeng SY, Lavik EB. Photopolymerizable nanoarray hydrogels deliver CNTF and promote differentiation of neural stem cells. Soft Matter 2010, 6:2208-2215.
131. Bertram JP, Williams CA, Robinson R, Segal SS, Flynn NT, Lavik EB. Intravenous hemostat: nanotechnology to halt bleeding. Sci Transl Med 2009, 1:11ra22.
132. Davis ME. The first targeted delivery of siRNA in humans via a self-assembling, cyclodextrin polymer-based nanoparticle: from concept to clinic. Mol Pharm 2009, 6:659-668.
133. Chen C, Okayama H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol Cell Biol 1987, 7:2745-2752.
134. Jordan M, Schallhorn A, Wurm FM. Transfecting mammalian cells: optimization of critical parameters affecting calcium-phosphate precipitate formation. Nucleic Acids Res 1996, 24:596-601.
135. Tolou H. Administration of oligonucleotides to cultured cells by calcium phosphate precipitation method. Anal Biochem 1993, 215:156-158.
136. Kakizawa Y, Kataoka K. Block copolymer self-assembly into monodispersive nanoparticles with hybrid core of antisense DNA and calcium phosphate. Langmuir 2002, 18:4539-4543.
137. Kakizawa Y, Furukawa S, Ishii A, Kataoka K. Organic-inorganic hybrid-nanocarrier of siRNA constructing through the self-assembly of calcium phosphate and PEG-based block aniomer. J Control Release 2006, 111:368-370.
138. Zhang M, Ishii A, Nishiyama N, Matsumoto S, Ishii T, Yamasaki Y, Kataoka K. PEGylated calcium phosphate nanocomposites as smart environment-sensitive carriers for siRNA delivery. Adv Mater 2009, 21:3520-3525.
139. Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 2005, 1:325-327.
140. Daniel MC, Astruc D. Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology. Chem Rev Columbus 2004, 104:293.
141. Ghosh PS, Kim CK, Han G, Forbes NS, Rotello VM. Efficient gene delivery vectors by tuning the surface charge density of amino acid-functionalized gold nanoparticles. ACS Nano 2008, 2:2213-2218.
142. Love JC, Estroff LA, Kriebel JK, Nuzzo RG, Whitesides GM. Self-assembled monolayers of thiolates on metals as a form of nanotechnology. Chem Rev Columbus 2005, 105:1103-1170.
143. Mirkin CA, Letsinger RL, Mucic RC, Storhoff JJ. A DNA-based method for rationally assembling nanoparticles into macroscopic materials. Nature 1996, 382:607-609.
144. Decher G, Hong JD. Buildup of ultrathin multilayer films by a self-assembly process, 1 consecutive adsorption of anionic and cationic bipolar amphiphiles on charged surfaces. In: Makromolekulare Chemie. Macromolecular Symposia: Wiley Online Library; 1991.
145. Meng H, Liong M, Xia T, Li Z, Ji Z, Zink JI, Nel AE. Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line. ACS Nano 2010, 4:4539-4550.
146. Gao X, Cui Y, Levenson RM, Chung LWK, Nie S. In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol 2004, 22:969-976.
147. Wu X, Liu H, Liu J, Haley KN, Treadway JA, Larson JP, Ge N, Peale F, Bruchez MP. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat Biotechnol 2002, 21:41-46.
148. Derfus AM, Chan WCW, Bhatia SN. Intracellular delivery of quantum dots for live cell labeling and organelle tracking. Adv Mater 2004, 16:961-966.
149. Derfus AM, Chan WCW, Bhatia SN. Probing the cytotoxicity of semiconductor quantum dots. Nano Lett 2004, 4:11-18.
150. Mattheakis LC, Dias JM, Choi YJ, Gong J, Bruchez MP, Liu J, Wang E. Optical coding of mammalian cells using semiconductor quantum dots. Anal Biochem 2004, 327:200-208.
151. Chen AA, Derfus AM, Khetani SR, Bhatia SN. Quantum dots to monitor RNAi delivery and improve gene silencing. Nucleic Acids Res 2005, 33:e190-e190.
152. Ameres SL, Martinez J, Schroeder R. Molecular basis for target RNA recognition and cleavage by human RISC. Cell 2007, 130:101-112.
153. Medarova Z, Pham W, Farrar C, Petkova V, Moore A. In vivo imaging of siRNA delivery and silencing in tumors. Nat Med 2007, 13:372-377.
154. Soutschek J, Akinc A, Bramlage B, Charisse K, Constien R, Donoghue M, Elbashir S, Geick A, Hadwiger P, Harborth J, et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 2004, 432:173-178.
155. Wolfrum C, Shi S, Jayaprakash KN, Jayaraman M, Wang G, Pandey RK, Rajeev KG, Nakayama T, Charrise K, Ndungo EM, et al. Mechanisms and optimization of in vivo delivery of lipophilic siRNAs. Nat Biotechnol 2007, 25:1149-1157.
156. Diegelman AM, Kool ET. Generation of circular RNAs and trans-cleaving catalytic RNAs by rolling transcription of circular DNA oligonucleotides encoding hairpin ribozymes. Nucleic Acids Res 1998, 26:3235-3241.